Verstrepen L - Search Results

1

TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.

Borghi A, Verstrepen L, Beyaert R. Borghi A, et al. Among authors: verstrepen l. Biochem Pharmacol. 2016 Sep 15;116:1-10. doi: 10.1016/j.bcp.2016.03.009. Epub 2016 Mar 16. Biochem Pharmacol. 2016. PMID: 26993379 Review.

2

TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme.

Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. Verstrepen L, et al. Cell Mol Life Sci. 2008 Oct;65(19):2964-78. doi: 10.1007/s00018-008-8064-8. Cell Mol Life Sci. 2008. PMID: 18535784 Free PMC article. Review.

3

Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.

Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R. Verstrepen L, et al. J Cell Mol Med. 2008 Jan-Feb;12(1):316-29. doi: 10.1111/j.1582-4934.2007.00187.x. Epub 2007 Dec 10. J Cell Mol Med. 2008. PMID: 18081698 Free PMC article.

4

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.

Verstrepen L, Carpentier I, Verhelst K, Beyaert R. Verstrepen L, et al. Biochem Pharmacol. 2009 Jul 15;78(2):105-14. doi: 10.1016/j.bcp.2009.02.009. Epub 2009 Feb 27. Biochem Pharmacol. 2009. PMID: 19464428 Review.

5

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R. Verstrepen L, et al. Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Biochem Pharmacol. 2010. PMID: 20599425 Review.

6

TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyond.

Verstrepen L, Verhelst K, Carpentier I, Beyaert R. Verstrepen L, et al. Trends Biochem Sci. 2011 Jul;36(7):347-54. doi: 10.1016/j.tibs.2011.03.004. Epub 2011 May 4. Trends Biochem Sci. 2011. PMID: 21546252 Review.

7

Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do not.

Verhelst K, Verstrepen L, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: verstrepen l. Biochem Pharmacol. 2011 Nov 1;82(9):1057-65. doi: 10.1016/j.bcp.2011.07.066. Epub 2011 Jul 20. Biochem Pharmacol. 2011. PMID: 21787758

8

IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer.

Verhelst K, Verstrepen L, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: verstrepen l. Biochem Pharmacol. 2013 Apr 1;85(7):873-80. doi: 10.1016/j.bcp.2013.01.007. Epub 2013 Jan 17. Biochem Pharmacol. 2013. PMID: 23333767 Free PMC article. Review.

9

Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammation.

Verstrepen L, Beyaert R. Verstrepen L, et al. Biochem Pharmacol. 2014 Dec 15;92(4):519-29. doi: 10.1016/j.bcp.2014.10.017. Epub 2014 Nov 7. Biochem Pharmacol. 2014. PMID: 25449604 Review.

10

LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.

Wullaert A, Verstrepen L, Van Huffel S, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, El Bakkouri K, Sanders M, Verhelst K, Carpentier I, Cavaillon JM, Heyninck K, Beyaert R. Wullaert A, et al. Among authors: verstrepen l. J Biol Chem. 2007 Jan 5;282(1):81-90. doi: 10.1074/jbc.M607481200. Epub 2006 Nov 6. J Biol Chem. 2007. PMID: 17088249 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters